TAIPEI – Taiwan plans to start development of a vaccine for the H7N9 avian flu strain as early as next week, seeking the help of private biotech companies ahead of expected samples of the new virus to be flown in from mainland China, where the disease has claimed more than a dozen lives to date.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?